Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07051278 · ClinicalTrials.gov registry record · NA
ABL90 FLEX PLUS Method Comparison Neonatal Capillary
A NA study of Method Comparison for ABL90 FLEX PLUS in Neonatal Subjects, sponsored by Radiometer Medical ApS.
- Completed
- Registry status
- NA
- Development phase
- 129
- Enrollment target
- 3
- Study locations
NCT07051278 is a NA study of Method Comparison for ABL90 FLEX PLUS in Neonatal Subjects that has completed, run by Radiometer Medical ApS. The registered enrollment target is 129 participants. The trial reports 3 study locations across 3 states.
The verdict
NCT07051278, a NA study of Method Comparison for ABL90 FLEX PLUS in Neonatal Subjects, has completed, sponsored by Radiometer Medical ApS.
- COMPLETED
- Registry status
- NA
- Development phase
- 129 participants
- Enrollment target
- 3
- Study locations
Study Summary
The study is intended to validate performance claims for method comparison for ABL90 FLEX PLUS in heparinized neonatal capillary whole blood for ctBil and FHbF in a POC setting
Conditions Studied
Interventions
- DEVICE Method Comparison
Study Locations (3)
New York
- Albert Einstein College of Medicine - The Bronx
North Carolina
- Duke University - Durham
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2023-11-10 |
| Est. Completion | 2025-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07051278
The ClinicalTrials.gov registry entry for NCT07051278 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radiometer Medical ApS, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Method Comparison for ABL90 FLEX PLUS in Neonatal Subjects appearing as the primary indexed condition, and to 1 intervention - of which Method Comparison is the first listed.
NCT07051278 reports 3 study locations spanning 3 distinct geographic areas - top geographies include New York, North Carolina, Virginia.
Frequently Asked Questions
What is clinical trial NCT07051278 about?
NCT07051278 is a clinical study titled "ABL90 FLEX PLUS Method Comparison Neonatal Capillary". The study is intended to validate performance claims for method comparison for ABL90 FLEX PLUS in heparinized neonatal capillary whole blood for ctBil and FHbF in a POC setting
What is the current status of trial NCT07051278?
This trial is currently completed. It is a NA study. The enrollment target is 129 participants. The study started on 2023-11-10. Estimated completion is 2025-01-31.
What conditions does trial NCT07051278 study?
This clinical trial studies the following conditions: Method Comparison for ABL90 FLEX PLUS in Neonatal Subjects.
What interventions are being tested in trial NCT07051278?
The interventions under investigation include: Method Comparison (DEVICE).
Who is sponsoring clinical trial NCT07051278?
This trial is sponsored by Radiometer Medical ApS, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07051278 being conducted?
This trial has 3 study locations across New York, North Carolina, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.